This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

On-Demand Symposia

On-Demand content available throughout the day with daily live speaker Q&A.

Government Pricing and Reporting 101
Government Pricing and Reporting 101

Calculations and Manufacturer Requirements Under the Medicaid Drug Rebate Program — AMP, BP and URA

Miree Lee, MS, MBA


Medicaid Rebate Processing, Contracting and Claims Considerations

Josephine Hawkins


ASP Calculations and Reporting in Part B

Kathleen Peterson


Mock Calculation Scenario Planning

Michael Fraclose
Miree Lee, MS, MBA


Live Speaker Q&A on Monday, September 14 from 3:30 – 4:00 (EST)
MDRP for the Seasoned Attendee
MDRP for the Seasoned Attendee

Impact of CMS’s Medicaid Block Grant Guidance

James Stansel


Best Practices to Track and Approach Fair Market Value

Steven Benz
Julie DeLong


Navigate the Financial Impacts of the Removal of AMP CAP

Brian McCartney


Operational Impacts of Value-Based Contracting and Executive Orders on GP

Mike Kurland


Live Speaker Q&A on Tuesday, September 15 from 3:30 – 4:00 (EST)

The A to Z Guide to FSS and Government Contracting
The A to Z Guide to FSS and Government Contracting

Key Concepts of FSS Contracting and Pricing Requirements

Elizabeth Lindquist


FCP and NFAMP Pricing Calculations and Program Nuances

Jennifer Plitsch


Country of Origin and Trade Agreement Act Compliance

Allison Pugsley


Year-End Pricing Process Update Under VA Covered Drug Program

Mark Myers


Live Speaker Q&A on Wednesday, September 16 from 3:30 – 4:00 (EST)
Medicaid and Rebate Operations
Medicaid and Rebate Operations

Innovation and Automation in Rebate Operations

Lynn Lewis


Measure the Impact of COVID-19 on State Medicaid Programs

State Efforts to Pursue Outcomes-Based Contracting in Medicaid

Overcome Complexities in Identifying and Managing 340B Claims and Invoices

Rich Holsapple, RPh


Live Speaker Q&A on Thursday, September 17 from 3:30 – 4:00 (EST)

IN-DEPTH, ON-DEMAND SESSIONS — WHAT YOU WANT. WHEN YOU WANT IT. ◎

On-Demand content is available anytime, to accommodate your needs and schedule.

INDUSTRY AND MDRP CRITICAL UPDATES
INDUSTRY AND MDRP CRITICAL UPDATES

HRSA Address — 340B Program Oversight and Initiatives

Krista Pedley, PharmD, MS, RADM, USPHS


CMS Address — MDRP Policy and Operational Updates

John Coster PhD, RPh


OIG Work Plan Update and Initiatives

David Tawes


340B Rebates — Do It Right

Jeremy Docken


Interesting Times – Operational Perspectives for Manufacturers Embracing the Tumultuous 2020 Landscape

Susan Dunne

REIMBURSEMENT AND CONTRACT STRATEGY
REIMBURSEMENT AND CONTRACT STRATEGY

Product Reimbursement and Coverage Under Parts B and D — Current Trends and Potential Changes in the Future

Stephanie Trunk


Medicaid Pharmacy Benefit Management — Managed Medicaid vs. Fee for Service 

Jennifer Lospinoso
Janice Matasi


CALCULATIONS AND REPORTING REQUIREMENTS
CALCULATIONS AND REPORTING REQUIREMENTS

Pricing Compendia/Unit of Measurement

Linda Schock
Michelle McLeod

340B POLICY, PROCESSES AND OVERSIGHT
340B POLICY, PROCESSES AND OVERSIGHT

Manufacturer Co-Pay Coupons and 340B — Working Together to Benefit the Patient

Micah Litow


340B Duplicate Discounts — What Happens When the Free Lunch is No Longer Available

Aaron Vandervelde


SMALL AND EMERGING BIOTECH STRATEGY
SMALL AND EMERGING BIOTECH STRATEGY

Product Launch Considerations and Ongoing Price Management

Shane Daniels
Kevin Tran


Government Pricing and Reimbursement Considerations for Innovative Gene Therapies

William Sarraille

FINANCIAL REPORTING AND OPERATIONS
FINANCIAL REPORTING AND OPERATIONS

Generic Product Launch Requirements, Pricing Decisions and Operational Considerations

Government Program Utilization and Gross-to-Net Accrual Rate Forecasting

Jen Sharpe